General MedicationsINTRAVENOUSGeneric
ARGATROBAN IN DEXTROSE
ARGATROBAN
Standard Dose
125MG/125ML (1MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ARGATROBAN IN DEXTROSE is listed in Drugs@FDA under application 201743 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ARGATROBAN Form and strength SOLUTION;INTRAVENOUS - 125MG/125ML (1MG/ML) Sponsor SANDOZ Submission history Latest submission status date: 2018-06-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview ARGATROBAN IN DEXTROSE is listed in Drugs@FDA under application 201743 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ARGATROBAN Form and strength SOLUTION;INTRAVENOUS - 125MG/125ML (1MG/ML) Sponsor SANDOZ Submission history Latest submission status date: 2018-06-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.